New program created to lower costs and improve productivity by inspiring a culture of wellness SPOKANE, Wash. APRIL 10, 2014 – Asuris has chosen Cerner Corporation to provide a web-based engagement platform that will allow the health insurer to deliver customizable, incentivized and measurable wellness programming for employers in Washington. The Cerner Wellness platform will […]
Portland, OR, APRIL 09, 2014 – Cambia is pleased to welcome Inderpal Bhandari as chief data officer for Cambia. In this newly created role, Inderpal will leverage his extensive experience in data analytics and management to lead the development of Cambia’s data strategy, and help drive the transformation of the company’s consumer experience strategies. “I […]
SPOKANE, Wash. APRIL 03, 2014 — Asuris Northwest Health announced today that it has been awarded Full Health Plan Accreditation for its commercial line of business from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry. This is the first time that Asuris sought, and received, health […]
Dr. Abigail Doyle (Associate Professor at Princeton University, USA) wins the „Chemistry“ category / Dr. Steven Spoel (Principal Investigator at the University of Edinburgh, UK) takes the „Biology“ award /Dr. Javier Fernandez (Associate Researcher at Wyss Institute/Harvard University, Boston, USA) awarded prize in the „Materials“ field Leverkusen, January 10, 2013 – The winners of the Bayer […]
Cambridge, Mass and Richmond, Calif. – January 9, 2014 – Biogen Idec (NASDAQ:BIIB) and Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today an exclusive worldwide collaboration and license agreement focused on the development of therapeutics for hemoglobinopathies, inherited conditions that result from the abnormal structure or underproduction of hemoglobin. The agreement will enable Biogen Idec to further enhance its […]
Special global web conference “One Health” to address zoonotic disease within the veterinary and public health fields Leverkusen, January 9, 2014 – Nearly half of the world’s population is infected with at least one type of vector-borne disease (1). These diseases are transmitted from parasites to animals and humans, and have a significant impact on public health […]
Pathway to Stop Diabetes will provide funding for innovative diabetes researchers Alexandria, VA (January 9, 2014) – With nearly 26 million adults and children in the U.S. living with diabetes, and another 79 million living with prediabetes, diabetes is a physical and financial burden for the health of the nation. To accelerate the research needed […]
NEW YORK, Jan. 9, 2014 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept) today announced that the FLINT trial of obeticholic acid (OCA) for the treatment of nonalcoholic steatohepatitis (NASH) has been stopped early for efficacy based on a planned interim analysis showing that the primary endpoint of the trial has been met. FLINT is a multi-center, double-blind, placebo-controlled […]
RICHMOND, Calif., Jan. 8, 2014 /PRNewswire/ — Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo’s president and chief executive officer, will present an update on Sangamo’s clinical and preclinical ZFP Therapeutic® programs and upcoming milestones, as well as an overview of the Company’s business strategy at the 32ND AnnualJ.P. Morgan Healthcare Conference on Thursday, January 16TH at 11:00 am PT in San Francisco. “Sangamo […]
January 8, 2014 – AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into an oncology research collaboration and licensing agreement with Immunocore Limited, a privately-held, UK-based biotechnology company. Both companies will research and develop novel cancer therapies using Immunocore’s Immune Mobilising Monoclonal T-Cell Receptor Against Cancer (ImmTAC) technology. This platform […]